Key result
Higher frailty linked to ~4% lower odds of good functional recovery after post-stroke thrombectomy.
Why the study?
Does frailty affect mortality and functional outcome in older stroke patients undergoing endovascular treatment?
Observational (n=2,468)
Yes
Does frailty affect mortality and functional outcome in older stroke patients undergoing endovascular treatment?
Answers are grounded in this paper and cite their sources.
Frailty is strongly associated with increased mortality and worse functional outcomes in older ischemic stroke patients undergoing endovascular thrombectomy.
Introduction: Frailty is a clinical syndrome particular in old patients with an increased risk of adverse health-care events. In geriatric stroke patients who received endovascular treatment, monocentric analyses have demonstrated that frailty affects mortality and functional outcome. We aimed to investigate the impact of frailty in a larger multicentric cohort. Patients and methods: We analyzed the impact of frailty on outcome in patients with stroke who underwent endovascular treatment in seven academic centers contributing to the German Stroke Registry. We calculated the Hospital Frailty Risk Score (HFRS) for all patients aged ⩾ 65 years. Functional outcome was measured by modified Rankin Scale (mRS) 3 months after the stroke event. A regression analysis conducted to assess mortality and functional outcome, adjusted for factors known to influence outcomes. Results: 2468 patients fulfilled the inclusion criteria. Median HFRS was 1.1 (IQR 0–2.95) and 449 (18.2%) patients had HFRS > 5. Low, intermediate and high-frailty risk was present in 2009 (71.7%), 389 (15.8%), and 60 (2.44%) respectively. A favorable neurological outcome (mRS 0–2) was achieved in 31.7%, 20.6%, and 13.8% in the low-, moderate, and high-risk-frailty-groups respectively (p < 0.001). Multivariate regression analysis showed a significant associations of HFRS on both mortality (adjusted OR 1.033, 95% CI: 1.004–1.063, p = 0.024) and functional outcome (adjusted OR: 0.962, 95% CI: 0.929–0.997; p = 0.033) after 3 months. However, there was no significant difference in baseline NHISS scores between frail and non-frail patients (14 (IQR 19–19)) vs 15 (IQR 11–19) vs 15 (IQR 10–19); p = 0.295). Besides door-to-groin time (DTN) differed with high frailty-risk patients having the longest DTN times (64 (38–102) vs 67.5 (45–95) vs 80 (54–106); p = 0.020). Discussion and conclusion: We identified frailty as a factor strongly associated with both mortality and functional outcome in ischemic stroke patients undergoing thrombectomy.
No takes yet. Share an insight, caveat, or question.
Schnieder et al. (2025) conducted an observational in Ischemic stroke (n=2,468). Frailty (Hospital Frailty Risk Score) vs. Low frailty risk was evaluated on Functional outcome (mRS 0-2) at 3 months (OR 0.962, 95% CI 0.929-0.997, p=0.033). Higher frailty risk was associated with worse functional outcome and increased mortality at 3 months in older stroke patients after thrombectomy.
Synapse has enriched 10 related papers. Consider them for comparative context: